Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) EBT (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of EBT data on record, last reported at -$9.2 million in Q3 2025.

  • For Q3 2025, EBT rose 4.34% year-over-year to -$9.2 million; the TTM value through Sep 2025 reached -$38.6 million, up 4.32%, while the annual FY2024 figure was -$39.8 million, 34.89% up from the prior year.
  • EBT reached -$9.2 million in Q3 2025 per ASMB's latest filing, up from -$10.2 million in the prior quarter.
  • Across five years, EBT topped out at -$8.8 million in Q1 2025 and bottomed at -$62.8 million in Q4 2021.
  • Average EBT over 5 years is -$18.7 million, with a median of -$16.9 million recorded in 2023.
  • Peak YoY movement for EBT: plummeted 461.45% in 2021, then surged 64.33% in 2022.
  • A 5-year view of EBT shows it stood at -$62.8 million in 2021, then soared by 64.33% to -$22.4 million in 2022, then soared by 51.2% to -$10.9 million in 2023, then rose by 4.74% to -$10.4 million in 2024, then increased by 11.67% to -$9.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$9.2 million in Q3 2025, -$10.2 million in Q2 2025, and -$8.8 million in Q1 2025.